Sign In
Buy AMLX
$13.20
-0.0900 (-0.677%)
At Close: Jun 03, 2026
Biotech Stocks Embrace The Neuroscience Renaissance With Biogen, Amylyx At The Helm
08:00am, Wednesday, 16'th Nov 2022
The neuroscience renaissance is here. Biotech stocks are soaring this year on expectations for new treatments in brain-health disorders.
Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2022 Earnings Call Transcript
09:10am, Sunday, 13'th Nov 2022
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Lindsey Allen - Head of Investor Relations and Communications Justin Klee
Stocks moving after hours: Twitter, Amylyx Pharmaceuticals, AutoZone, Airbnb
06:30pm, Tuesday, 04'th Oct 2022
Yahoo Finance Live's Seana Smith looks at several stocks trending in the after-hours trading session.
Amylyx Shows FDA Can Be Flexible on Drugs for Diseases With Few Treatments
10:36am, Friday, 30'th Sep 2022
Relvyrio, Amylyx's drug to treat ALS, a neurological disorder without a cure, was approved even though the treatment is very expensive.
IPO Scorcher Amylyx Wins FDA Approval In ALS Treatment, Ending A Long Battle
06:07pm, Thursday, 29'th Sep 2022
After a long road, Amylyx Pharmaceuticals won FDA approval for its ALS treatment late Thursday, leading AMLX stock to surge. The post IPO Scorcher Amylyx Wins FDA Approval In ALS Treatment, Ending A L
Amylyx's ALS Drug Is Approved by the FDA
05:28pm, Thursday, 29'th Sep 2022
The drug is the first that the Food and Drug Administration has approved for ALS, also known as Lou Gehrig's disease, in five years.
Amylyx's ALS drug wins FDA approval despite questionable data
05:14pm, Thursday, 29'th Sep 2022
WASHINGTON — A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind governmen
3 IPO Stocks That You Want to Own
09:23am, Sunday, 25'th Sep 2022
This down market is giving us some really intriguing stocks at cheap prices.
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
09:07am, Monday, 12'th Sep 2022
Amylyx Pharmaceuticals has just one drug in its pipeline -- but it's for ALS, and the available treatments for that disease leave much to be desired.
Does a Revolutionary New ALS Drug Make This Biotech Stock a Buy Now?
05:41am, Sunday, 11'th Sep 2022
The FDA will most likely approve this company's first drug, but what comes next is more difficult to predict.
Amylyx (AMLX) Up 51% After FDA Committee Endorses ALS Drug
01:33pm, Friday, 09'th Sep 2022
The FDA's PCNSDAC recommends granting marketing approval to Amylyx's (AMLX) oral drug, which slows the progression of ALS.
Why Amylyx Pharmaceuticals Stock Is on Fire Today
11:19am, Thursday, 08'th Sep 2022
The drugmaker's ALS drug got a thumbs-up from a panel of experts yesterday.
Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 70% Today?
09:46am, Thursday, 08'th Sep 2022
Source: JHVEPhoto / Shutterstock.com Amylyx Pharmaceuticals (NASDAQ: AMLX ) stock is rocketing higher on Thursday following an update from the FDA on its ALS treatment. A letter from the FDA reveals t
The FDA's Mixed Messages Sent Amylyx Pharmaceuticals Stock Off A Cliff
01:45pm, Friday, 02'nd Sep 2022
The FDA offered mixed messages Friday for Amylyx Pharmaceuticals' experimental neurological disease treatment, and AMLX stock crashed. The post The FDA's Mixed Messages Sent Amylyx Pharmaceuticals Sto
Is a Surprise Coming for Amylyx Pharmaceuticals (AMLX) This Earnings Season?
09:47am, Wednesday, 10'th Aug 2022
Amylyx Pharmaceuticals (AMLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
